An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Guardant Health to Participate in Upcoming November Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Guardant Health, Inc. (Nasdaq: GH) will be participating in two upcoming investor conferences: Jefferies 14th Annual Global Healthcare Conference in London, UK on November 16 at 9:00 a.m. GMT and Piper Sandler 35th Annual Healthcare Conference in New York, NY on November 28 at 9:30 a.m. ET. Interested parties can access live and archived webcasts of the sessions on the company website at www.guardanthealth.com.
Positive
None.
Negative
None.
PALO ALTO, Calif.--(BUSINESS WIRE)--
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences:
Jefferies 14th Annual Global Healthcare Conference in London, UK Presentation on Thursday, November 16 at 9:00 a.m. Greenwich Mean Time
Piper Sandler 35th Annual Healthcare Conference in New York, NY Fireside Chat on Tuesday, November 28 at 9:30 a.m. Eastern Time
Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused on helping every person live a life free from cancer. Founded in 2012, Guardant is transforming cancer care by providing critical insights into what drives the disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve patient outcomes across all stages of cancer, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn and X (Twitter).
Which investor conferences will Guardant Health be participating in?
Guardant Health will be participating in Jefferies 14th Annual Global Healthcare Conference in London, UK and Piper Sandler 35th Annual Healthcare Conference in New York, NY.
When and at what times will the conferences take place?
The Jefferies conference will take place on November 16 at 9:00 a.m. GMT, and the Piper Sandler conference will take place on November 28 at 9:30 a.m. ET.
How can interested parties access the conference sessions?
Interested parties can access live and archived webcasts of the sessions on the "Investors" section of the company website at www.guardanthealth.com.
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
